Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.200
+0.010 (0.46%)
Nov 20, 2024, 4:00 PM EST - Market closed
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $7.14 million as of November 21, 2024. Its market cap has decreased by -27.84% in one year.
Market Cap
7.14M
Enterprise Value
5.14M
1-Year Change
-27.84%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since November 5, 2015, Edesa Biotech's market cap has decreased from $74.90M to $7.14M, a decrease of -90.46%. That is a compound annual growth rate of -22.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 7.10M | -51.03% |
| Dec 29, 2023 | 14.50M | -65.31% |
| Dec 30, 2022 | 41.80M | -45.07% |
| Dec 31, 2021 | 76.10M | 70.25% |
| Dec 31, 2020 | 44.70M | 45.13% |
| Dec 31, 2019 | 30.80M | 528.57% |
| Dec 31, 2018 | 4.90M | -42.35% |
| Dec 29, 2017 | 8.50M | -58.74% |
| Dec 30, 2016 | 20.60M | -62.34% |
| Dec 31, 2015 | 54.70M | -26.97% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardio Diagnostics Holdings | 7.42M |
| Evoke Pharma | 7.25M |
| BioCardia | 7.11M |
| Plus Therapeutics | 7.02M |
| ABVC BioPharma | 6.78M |
| Brainstorm Cell Therapeutics | 6.75M |
| ATI Physical Therapy | 6.65M |
| Addex Therapeutics | 6.64M |